{
    "type": "VariantTherapeuticResponseProposition",
    "predicate": "sensitivity",
    "description": "Treatment of pediatric patients 1 year of age and older with Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase",
    "geneContextQualifier": "BCR | ABL1",
    "objectTherapeutic": "Dasatinib [Sprycel]"
}